Patient Strategies to Cope with High Prescription Medication Costs: Who is Cutting Back on Necessities, Increasing Debt, or Underusing Medications?
- 1 February 2005
- journal article
- Published by Springer Nature in Journal of Behavioral Medicine
- Vol. 28 (1) , 43-51
Abstract
Many chronically ill adults in the United States face high prescription medication costs, yet little is known about the strategies patients adopt to cope with these costs. Through a national survey of 4,055 adults taking prescription medications for one of five chronic diseases, we compared whether respondents cut back on necessities such as food or heat to pay for medications, increased debt, or underused medications because of cost. We also examined the sociodemographic and clinical correlates and differential use by different sub-groups of these three strategies. Overall, 31% of respondents reported pursuing at least one of the strategies over the prior 12 months. Twenty-two percent had cut back on necessities, 16% had increased their debt burden, and 18% had underused prescription drugs. Among patients who underused their medication, 67% also had cut necessities or increased debt. Although we found significant differences in the way patients with varying socio-demographic characteristics responded to medication cost pressures, use of all these strategies was especially common among patients who were low-income, in poor health, and taking multiple medications.Keywords
This publication has 26 references indexed in Scilit:
- Health Insurance Status, Cost-Related Medication Underuse, and Outcomes Among Diabetes Patients in Three Systems of CareMedical Care, 2004
- Can High Quality Overcome Consumer Resistance to Restricted Provider Access? Evidence from a Health Plan Choice ExperimentHealth Services Research, 2002
- Prescription Drug Coverage And Seniors: How Well Are States Closing The Gap?Health Affairs, 2002
- Self-restriction of medications due to cost in seniors without prescription coverageJournal of General Internal Medicine, 2001
- The Case for a Medicare Drug Coverage Benefit: A Critical Review of the Empirical EvidenceAnnual Review of Public Health, 2001
- Patient Self-Reports in Pharmacoeconomic StudiesPharmacoEconomics, 1999
- Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with SchizophreniaNew England Journal of Medicine, 1994
- Recall bias in epidemiologic studiesJournal of Clinical Epidemiology, 1990
- Payment Restrictions for Prescription Drugs under MedicaidNew England Journal of Medicine, 1987
- Predictors of Recall of Medication Regimens and Recommendations for Lifestyle Change in Elderly PatientsThe Gerontologist, 1987